Nrf2 Mediates the Induction of Ferritin H in Response to Xenobiotics and Cancer Chemopreventive Dithiolethiones
Open accessThe DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Abstract
Ferritin is a ubiquitous intracellular iron storage protein that consists of 24 subunits of the H and L type. The ability to sequester iron from participation in oxygen free radical formation is consistent with a cytoprotective role for ferritin. Here we demonstrate that ferritins H and L are induced in cells treated with beta-napthoflavone (beta-NF) and chemopreventive dithiolethiones. Induction of ferritin H by beta-NF and the dithiolethiones oltipraz and 1,2-dithiole-3-thione (D3T) occurs via a transcriptional mechanism that is mediated by the ferritin H electrophile/antioxidant-responsive element (EpRE/ARE). The murine ferritin H gene contains five potential xenobiotic-responsive element (XRE) sequences in its 5'-promoter region. However, deletion analysis demonstrates that these XRE sequences are not functional in inducing ferritin H in response to beta-NF. Electrophoretic mobility shift assays demonstrate that the ferritin H EpRE/ARE binds Nrf2. Transfection of chimeric ferritin H reporter genes with Nrf2 expression vectors and Nrf2 dominant-negative mutants indicate that Nrf2 functions at the EpRE/ARE to mediate transcriptional activation of ferritin H. Induction of ferritin H and L was not seen in Nrf2 knockout cells, demonstrating that this transcription factor is required for the induction of ferritin in response to polycyclic aromatic xenobiotics and chemopreventive agents. Nrf2 may also play a role in basal transcription of both ferritin H and L. These results provide a mechanistic link between regulation of the iron storage protein ferritin and the cancer chemopreventive response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rising heme levels induce Bach1 proteosomal degradation, releasing the brake on two types of down-stream pathways. First, the competitive inhibition of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) binding to antioxidant-response elements (ARE) ceases for genes containing AREs [51, 145, 221], such as ferritin h chain (FTH), FPN1, heme-regulated gene-1 (HRG1), and heme oxygenase (Hmox1) [102,”
From “Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels (2017) · cites this paper as [190]
In the citing paper
“Activation of the transcription factor nuclear factor E2-related factor-2 (Nrf2), in response to oxidative stress, is another important mechanism regulating ferritin expression (51).”
From Innate Nutritional Immunity (2018) · cites this paper as [51]
In the citing paper
“Serum ferritin has been thought to reflect the iron stores in the body and to increase as a secreted byproduct of intracellular ferritin synthesis (250, 297).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [250]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Karin, M., Liu, Z.-G., & Zandi, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80068-3 · Cited by 2,893
The ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Rushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464
FERRITIN: STRUCTURE, GENE REGULATION, AND CELLULAR FUNCTION IN ANIMALS, PLANTS, AND MICROORGANISMS
Theil, E. C. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.001445 · Cited by 1,350
Research works printed but not linked: 4
- Prochaska, 1988, Cancer Res., 48, 4776
- Bergelson, 1994, Oncogene, 9, 565
- McMahon, 2001, Cancer Res., 61, 3299
- Thimmulappa, 2002, Cancer Res., 62, 5196
Cited by
Items 101–200 of 285
Emerging Regulatory Role of Nrf2 in Iron, Heme, and Hemoglobin Metabolism in Physiology and Disease
Kasai, S., Mimura, J., Ozaki, T., & Itoh, K. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00242 · Cited by 75
Nakajima, H., Nakajima‐Takagi, Y., Tsujita, T., Akiyama, S.-I., Wakasa, T., Mukaigasa, K., Kaneko, H., Tamaru, Y., Yamamoto, M. P., & Kobayashi, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026884 · Cited by 74
Iron and liver cancer: an inseparable connection
Hino, K., Yanatori, I., Hara, Y., & Nishina, S. (2021) · FEBS Journal · doi:10.1111/febs.16208 · Cited by 76
The p65 Isoform of Nrf1 Is a Dominant Negative Inhibitor of ARE-mediated Transcription
Wang, W., Kwok, A. M., & Chan, J. Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700159200 · Cited by 69
Self-citationCataneo, A. H. D., Tomiotto‐Pellissier, F., Miranda-Sapla, M. M., Assolini, J. P., Panis, C., Kian, D., Yamauchi, L. M., Simão, A. N. C., Casagrande, R., Pinge‐Filho, P., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108745 · Cited by 77
Cheng, J., Xu, T., Xun, C., Guo, H., Cao, R., Gao, S., & Sheng, W. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118905 · Cited by 66
Egbujor, M. C., Buttari, B., Profumo, E., Telkoparan‐Akillilar, P., & Saso, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158466 · Cited by 70
The Role of Nrf2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells
Rushworth, S. A., & MacEwan, D. J. (2011) · Cancers · doi:10.3390/cancers3021605 · Cited by 69
Salatino, A., Aversa, I., Battaglia, A. M., Sacco, A., Vito, A. D., Santamaria, G., Chirillo, R., Veltri, P., Tradigo, G., Cello, A. D., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3461251 · Cited by 65
Glyphosate Triggers Ferroptosis Via Suppressing Nrf2/Gsh Axis in Liver Cells
Liu, J., Yang, G., & Zhang, H. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.160839 · Cited by 64
Newly uncovered biochemical and functional aspects of ferritin
Yanatori, I., Nishina, S., Kishi, F., & Hino, K. (2023) · The FASEB Journal · doi:10.1096/fj.202300918r · Cited by 70
Rushworth, S. A., Bowles, K. M., Raninga, P., & MacEwan, D. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3407 · Cited by 62
Nrf2 deficiency causes tooth decolourization due to iron transport disorder in enamel organ
Yanagawa, T., Itoh, K., Uwayama, J., Shibata, Y., Yamaguchi, A., Sano, T., Ishii, T., Yoshida, H., & Yamamoto, M. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00753.x · Cited by 61
Keap1 eye on the target: chemoprevention of liver cancer
Yates, M. S., & Kensler, T. W. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00688.x · Cited by 63
Castorena‐Torres, F., de León, M. B., Cisneros, B., Zapata‐Pérez, O., Salinas, J. E., & Albores, A. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.10.009 · Cited by 66
Satarug, S., Ujjin, P., Vanavanitkun, Y., Nishijo, M., Baker, J. R., & Moore, M. R. (2004) · Toxicology · doi:10.1016/j.tox.2004.06.022 · Cited by 65
GSK-3β manipulates ferroptosis sensitivity by dominating iron homeostasis
Wang, L., Ouyang, S., Li, B., Wu, H., & Wang, F. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00726-3 · Cited by 66
Jiang, S., Xiao, X., Li, J., & Mu, Y. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.04.020 · Cited by 65
Ferritinophagy and Ferroptosis in Cerebral Ischemia Reperfusion Injury
Liu, X., Xie, C., Wang, Y., Xiang, J., Chen, L., Yuan, J. Y., Chen, C., & Tian, H.-M. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04161-5 · Cited by 74
Dopamine activates Nrf2‐regulated neuroprotective pathways in astrocytes and meningeal cells
Shih, A. Y., Erb, H., & Murphy, T. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04345.x · Cited by 60
Crosstalk of Nrf2 with the Trace Elements Selenium, Iron, Zinc, and Copper
Schwarz, M., Lossow, K., Kopp, J. F., Schwerdtle, T., & Kipp, A. P. (2019) · Nutrients · doi:10.3390/nu11092112 · Cited by 64
Veitch, Z. W. N., Guo, B., Hembruff, S. L., Bewick, A. J., Heibein, A. D., Eng, J., Cull, S., Maclean, D. A., & Parissenti, A. M. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832c484b · Cited by 60
Deng, Z., Manz, D. H., Torti, S. V., & Torti, F. M. (2017) · Oncotarget · doi:10.18632/oncotarget.19288 · Cited by 55
Self-citationPotential Role of H-Ferritin in Mitigating Valvular Mineralization
Sikura, K. É., Potor, L., Szerafin, T., Zarjou, A., Agarwal, A., Arosio, P., Poli, M., Hendrik, Z., Méhes, G., Oros, M., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.312191 · Cited by 64
The Antioxidant/electrophile Response Element Motif
Nerland, D. E. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601125000 · Cited by 64
Tanaka, Y., Ikeda, T., Yamamoto, K., Ogawa, H., & Kamisako, T. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07180.x · Cited by 53
Sun, R., Liu, M., Xu, K., Pu, Y., Huang, J., Liu, J., Zhang, J., Yin, L., & Pu, Y. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110004 · Cited by 55
Nrf2 to Pre-condition the Brain Against Injury Caused by Products of Hemolysis After ICH
Zhao, X., & Aronowski, J. A. (2013) · Translational Stroke Research · doi:10.1007/s12975-012-0245-y · Cited by 56
Huang, B., Ray, P. D., Iwasaki, K., & Tsuji, Y. (2013) · The FASEB Journal · doi:10.1096/fj.12-226043 · Cited by 52
Leśniak, W., Szczepańska, A., & Kuźnicki, J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.11.003 · Cited by 53
Panieri, E., & Saso, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8146 · Cited by 49
Nrf2 transcriptional derepression from Keap1 by dietary polyphenols
Bayele, H. K., Debnam, E. S., & Srai, S. K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.103 · Cited by 50
Nrf2 knockout dysregulates iron metabolism and increases the hemolysis through ROS in aging mice
Liu, Z., Han, K., Huo, X., Yan, B., Gao, M., Lv, X., Yu, P., Gao, G., & Chang, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117838 · Cited by 46
Dai, W., Xu, B., Ding, L., Zhang, Z., Hong, Y., He, T., Liu, L., Pei, X., & Fu, X. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.04.229 · Cited by 49
Ferroptosis in Friedreich’s Ataxia: A Metal-Induced Neurodegenerative Disease
Rosa, P. L., Petrillo, S., Fiorenza, M. T., Bertini, E., & Piemonte, F. (2020) · Biomolecules · doi:10.3390/biom10111551 · Cited by 53
Nrf2 as a master regulator of tissue damage control and disease tolerance to infection
Soares, M. P., & Ribeiro, A. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150054 · Cited by 48
Huang, B., Miyazawa, M., & Tsuji, Y. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.018 · Cited by 49
The molecular biology and therapeutic potential of Nrf2 in leukemia
Khodakarami, A., Adibfar, S., Karpisheh, V., Abolhasani, S., Jalali, P., Mohammadi, H., Navashenaq, J. G., Hojjat‐Farsangi, M., & Jadidi‐Niaragh, F. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02660-5 · Cited by 47
Liu, X., Li, H., Liu, L., Lu, Y., Gao, Y., Geng, P., Li, X., Huang, B., Zhang, Y., & Lü, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.05.009 · Cited by 51
Killeen, M. E., Englert, J. A., Stolz, D. B., Song, M., Han, Y., Delude, R. L., Kellum, J. A., & Fink, M. P. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092841 · Cited by 45
Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells
Zhang, L., Zhang, J., Jin, Y., Yao, G., Zhao, H., Qiao, P., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728172 · Cited by 53
Iwasaki, K., Hailemariam, K., & Tsuji, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701477200 · Cited by 41
Iron deficiency and supplementation in heart failure
Lakhal‐Littleton, S., & Cleland, J. G. F. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-00988-1 · Cited by 54
Tissue-specific expression of ferritin H regulates cellular iron homoeostasis in vivo
Wilkinson, J., Di, X., Schönig, K., Buss, J. L., Kock, N. D., Cline, J. M., Saunders, T. L., Bujard, H., Torti, S. V., & Torti, F. M. (2006) · Biochemical Journal · doi:10.1042/bj20060063 · Cited by 41
Self-citationPharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells
Becs, G., Zarjou, A., Agarwal, A., Kovács, K. É., Becs, Á., Nyitrai, M., Balogh, E., Bányai, E., Eaton, J. W., Arosio, P., et al. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12682 · Cited by 42
Regulation and Reconstruction of Cell Phenotype Gradients Along the Tendon‐Bone Interface
Dang, G., Qin, W., Wan, Q., Gu, J., Wang, K., Mu, Z., Gao, B., Jiao, K., Tay, F. R., & Niu, L. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202210275 · Cited by 40
Advances in Ferritin Physiology and Possible Implications in Bacterial Infection
Gehrer, C. M., Mitterstiller, A., Grubwieser, P., Meyron‐Holtz, E. G., Weiß, G., & Nairz, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054659 · Cited by 45
Ferroptosis: A new insight for treatment of acute kidney injury
Li, S., Wang, R., Wang, Y., Liu, Y., Qiao, Y., Li, P., Chen, J., Pan, S., Feng, Q., Liu, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1065867 · Cited by 43
The Potential Role of Major Argan Oil Compounds as Nrf2 Regulators and Their Antioxidant Effects
Kebbaj, R. E., Bouchab, H., Tahri-Joutey, M., Rabbaa, S., Limami, Y., Nasser, B., Egbujor, M. C., Tucci, P., Andreoletti, P., Saso, L., et al. (2024) · Antioxidants · doi:10.3390/antiox13030344 · Cited by 44
Ren, C., Chen, T., Jiang, X., Wang, Y., & Hu, C. (2014) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2014.03.022 · Cited by 41
Valerio, L. G. (2007) · Toxicology Mechanisms and Methods · doi:10.1080/15376510701556690 · Cited by 37
DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms
Lemler, D. J., Lynch, M. L., Tesfay, L., Deng, Z., Paul, B. T., Wang, X., Hegde, P., Manz, D. H., Torti, S. V., & Torti, F. M. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0814-9 · Cited by 38
Self-citationWati, S. M., Matsumaru, D., & Motohashi, H. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101603 · Cited by 45
Turpaev, K. T., Ermolenko, M. S., Cresteil, T., & Drapier, J. C. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.028 · Cited by 40
FTH1 binds to Daxx and inhibits Daxx-mediated cell apoptosis
Liu, F., Du, Z., He, J., Liu, X., Yu, Q., & Wang, Y. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0811-5 · Cited by 38
Hoyt, M. T., Palchaudhuri, R., & Hergenrother, P. J. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9390-x · Cited by 37
Role of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier
Cazalla, E., Cuadrado, A., & García‐Yagüe, Á. J. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00599-5 · Cited by 41
Triad role of hepcidin, ferroportin, and Nrf2 in cardiac iron metabolism: From health to disease
Jayakumar, D., Narasimhan, K. K. S., & Kalaiselvi, P. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126882 · Cited by 35
Semi-artificial and bioactive ferroxidase with nanoparticles as the active sites
Li, L., Zhang, L., Carmona, U., & Knez, M. (2014) · Chemical Communications · doi:10.1039/c4cc03477e · Cited by 30
Chifman, J., Arat, S., Deng, Z., Lemler, E., Pino, J. C., Harris, L. A., Kochen, M. A., Lopez, C. F., Akman, S. A., Torti, F. M., et al. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005352 · Cited by 31
Self-citationZhao, X., Kang, Z., Han, R., Wang, M., Wang, Y., Sun, X., Wang, C., Zhou, J., Cao, L., & Lu, M. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103190 · Cited by 34
Uncovering the Metabolic and Stress Responses of Human Embryonic Stem Cells to FTH1 Gene Silencing
Scaramuzzino, L., Lucchino, V., Scalise, S., Conte, M. L., Zannino, C., Sacco, A., Biamonte, F., Parrotta, E. I., Costanzo, F. S., & Cuda, G. (2021) · Cells · doi:10.3390/cells10092431 · Cited by 30
Li, Y., Ruan, X., Sun, M., Yuan, M., Song, J. Y., Zhou, Z., Li, H., Ma, Y., Mi, W., & Zhang, X. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114862 · Cited by 34
Therapeutic potential of dithiolethiones for hepatic diseases
Brooks, S. C., Brooks, J. S., Lee, W. H., Lee, M. G., & Kim, S. G. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.006 · Cited by 30
The core control system of intracellular iron homeostasis: A mathematical model
Chifman, J., Kniss, A., Neupane, P., Williams, I., Leung, B., Deng, Z., Mendes, P., Hower, V., Torti, F. M., Akman, S. A., et al. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.01.024 · Cited by 37
Self-citationCytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury
Hatcher, H., Tesfay, L., Torti, S. V., & Torti, F. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138505 · Cited by 30
Self-citationFerritin in Kidney and Vascular Related Diseases: Novel Roles for an Old Player
Balla, J., Balla, G., & Zarjou, A. (2019) · Pharmaceuticals · doi:10.3390/ph12020096 · Cited by 32
Troadec, M., Glaise, D., Lamirault, G., Cunff, M. L., Guérin, É., Meur, N. L., Détivaud, L., Zindy, P. J., Leroyer, P., Guisle, I., et al. (2005) · Genomics · doi:10.1016/j.ygeno.2005.08.016 · Cited by 28
The roles of sirtuins in ferroptosis
Zeng, J., Guo, J., Huang, S., Cheng, Y., Luo, F., Xu, X., Chen, R., Ma, G., & Wang, Y. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1131201 · Cited by 34
Hasan, S. K., Jayakumar, S., Barroso, E. E., Jha, A., Catalano, G., Sandur, S. K., & Noguera, N. I. (2025) · Cells · doi:10.3390/cells14100713 · Cited by 32
NRF2: Master regulator of cellular homeostasis and therapeutic vulnerability in cancer
Chen, W.-T., McKee, N. W., Kuhnell, D., & Dodson, M. B. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104050 · Cited by 30
Nanoceria distribution and effects are mouse-strain dependent
Yokel, R. A., Tseng, M. T., Butterfield, D. A., Hancock, M. L., Grulke, E. A., Unrine, J. M., Stromberg, A. J., Dozier, A., & Graham, U. M. (2020) · Nanotoxicology · doi:10.1080/17435390.2020.1770887 · Cited by 25
The role of the endoplasmic reticulum stress in depression
Kowalczyk, M., Majsterek, I., Gałecki, P., & Talarowska, M. E. (2020) · Psychiatria Polska · doi:10.12740/pp/109130 · Cited by 24
Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside
Dong, Y., Zheng, M., Ding, W., Guan, H., Xiao, J., & Li, F. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103551 · Cited by 26
Tsuji, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043604 · Cited by 25
Ferritin H induction by histone deacetylase inhibitors
Wang, W., Di, X., Torti, S. V., & Torti, F. M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.008 · Cited by 23
Self-citationWang, C., Zhou, Y.-L., Zhu, Q.-H., Zhou, Z., Gu, W.-B., Liu, Z.-P., Wang, L.-Z., & Shu, M.-A. (2018) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2018.07.016 · Cited by 23
Ko, M. S., Lee, S. J., Kim, J. W., Lim, J. W., & Kim, S. G. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009514 · Cited by 21
Ye, Z., Li, C., Liu, S., Liang, H., Feng, J., Lin, D., Chen, Y., Peng, S., Bu, L., Tao, E., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110604 · Cited by 21
Transcription Factor NRF2 in Shaping Myeloid Cell Differentiation and Function
Pfefferlé, M., & Vallelian, F. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_8 · Cited by 18
Kuo, Y.-L., Chen, C., Chuang, T., Hua, W.-K., Lin, W., Hsu, W., Chang, P. M., Hsu, S., Huang, T., Kao, C.-Y., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/917345 · Cited by 22
Morozova, N., Khrapko, K., Panee, J., Liu, W., Harney, J. W., & Berry, M. J. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01074.x · Cited by 18
Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors
Sparaneo, A., Fabrizio, F. P., la Torre, A., Graziano, P., Maïo, M. D., Fontana, A., Bisceglia, M., Rossi, A., Pizzolitto, S., Maglio, G. D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102531 · Cited by 18
Khodakarami, A., Kashani, M. A., Nazer, A., Kheshti, A. M., Rashidi, B., Karpisheh, V., Masjedi, A., Abolhasani, S., Izadi, S., Bagherifar, R., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01213-1 · Cited by 18
Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications
Qiu, M., Ma, K., Zhang, J., Zhao, Z., Wang, S., Wang, Q., & Xu, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1395735 · Cited by 21
Piton, A., Rauch, C., Langouët, S., Guillouzo, A., & Morel, F. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.09.025 · Cited by 15
Sun, S., Gu, Z., Fu, H., Zhu, J. X., Xuan, F., & Ge, X. (2014) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2014.07.002 · Cited by 13
Dietary and Sentinel Factors Leading to Hemochromatosis
Oh, C.-K., & Moon, Y. (2019) · Nutrients · doi:10.3390/nu11051047 · Cited by 12
Wei, S., Wang, Y., Chai, Q., Fang, Q., Zhang, Y., & Wang, J. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2209 · Cited by 11
RetractedOxidative Stress and Changed Gene Expression Profiles in Fiber-/Particle-Induced Carcinogenesis
Bhattacharya, K., Alink, G. M., & Dopp, E. (2007) · International Journal of Human Genetics · doi:10.1080/09723757.2007.11885981 · Cited by 14
Iron–Sulfur Cluster Metabolism Impacts Iron Homeostasis, Ferroptosis Sensitivity, and Human Disease
Sviderskiy, V. O., Terzi, E. M., & Possemato, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-26780-3_12 · Cited by 14
Mieszkowski, J., Kochanowicz, M., Żychowska, M., Kochanowicz, A., Grzybkowska, A., Anczykowska, K., Sawicki, P., Borkowska, A., Niespodziński, B., & Antosiewicz, J. (2019) · BioMed Research International · doi:10.1155/2019/9576876 · Cited by 13
The cross-talk and interplay between ferroptosis and cuproptosis in tumor and therapeutics
Zhou, X., & Peng, S. (2026) · Cellular Oncology · doi:10.1007/s13402-025-01138-6 · Cited by 16
The role of iron in normal and impaired testicular function
Harrer, A., Meyron‐Holtz, E. G., & Meinhardt, A. (2025) · Andrology · doi:10.1111/andr.70068 · Cited by 14
Milczarek, A., Starzyński, R. R., Styś, A., Jończy, A., Staroń, R., Grzelak, A., & Lipiński, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176800 · Cited by 10
Li, J., Lee, J., Johnson, D. A., & Johnson, J. A. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)78019-2 · Cited by 10
Shang, M., Ning, J., Zang, C., Ma, J., Yang, Y., Jiang, Y., Chen, Q., Dong, Y., Wang, J., Li, F., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.011 · Cited by 12
Exerkines: Potential regulators of ferroptosis
Jia, M., Li, F., Wu, T., & Chen, N. (2025) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2025.101032 · Cited by 10
Fuhrmann, D. C., Becker, S. A., & Brüne, B. (2022) · FEBS Letters · doi:10.1002/1873-3468.14545 · Cited by 10
Tomoo, N. A. O. I., Shibuya, N., INOUE, H., Mita, S., Kobayashi, S., Watanabe, K., & Orino, K. (2010) · Journal of Veterinary Medical Science · doi:10.1292/jvms.09-0346 · Cited by 11
Metadata
- Authors
- Pietsch, E. C., Chan, J. Y., Torti, F. M., & Torti, S. V.
- Affiliations
- Wake Forest University Health Sciences (US)
- University of California, Irvine (US)
- Corresponding author
- Torti, Suzy V.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 278
- Issue
- 4
- Pages
- 2361-2369
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2123082386
- Cited by
- 284
- References
- 82
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 14 · 2023: 23 · 2022: 15 · 2021: 13 · 2020: 17 · 2019: 13 · 2018: 10 · 2017: 13 · 2016: 2 · 2015: 12 · 2014: 11 · 2013: 13 · 2012: 7
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6497 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-42412, DK17282)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- Nrf2, H-ferritin, iron storage protein, dithiolethiones, oltipraz, 1,2-dithiole-3-thione, beta-naphthoflavone, xenobiotic response element, transcriptional regulation, chemoprevention, polycyclic aromatic hydrocarbons, antioxidant response
- MeSH terms
- Animals, Antineoplastic Agents, Base Sequence, Cell Line, DNA-Binding Proteins, Enzyme Inhibitors, Ferritins, Humans, Iron, Models, Biological, Models, Genetic, Molecular Sequence Data, Plasmids, Protein Binding, Pyrazines, Thiones, Thiophenes, Time Factors, Transcription, Genetic, Tumor Cells, Cultured, Blotting, Northern, Xenobiotics, Transcriptional Activation, Trans-Activators, 3T3 Cells, Anticarcinogenic Agents, Gene Deletion, Protein Structure, Tertiary, Genes, Reporter, beta-Naphthoflavone, Response Elements, NF-E2-Related Factor 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.